AI Science Tracker

FragFold identifies inhibitory fragments within bacterial proteins

Massachusetts Institute of Technology · 20 Feb 2025 · biology

Discovery

FragFold identifies inhibitory fragments within bacterial proteins

MIT researchers used FragFold, an AlphaFold-based approach, to predict fragments that bind to and inhibit full-length proteins in E. coli. The researchers experimentally confirmed more than half of its binding or inhibition predictions, including cases without prior structural interaction data.

Technology: FragFold, using AlphaFold

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The researchers experimentally confirmed more than half of its binding or inhibition predictions, including cases without prior structural interaction data.
  • Still unknown: The institutional report says more than half of predictions were accurate; this is a study-specific validation result, not a general success rate across proteins or organisms.
  • AI role: Researchers computationally fragmented bacterial proteins and used AlphaFold predictions to nominate inhibitory fragments; experiments tested binding and inhibition. The AI supplied structural predictions, not experimental verification.

Evidence sources: https://news.mit.edu/2025/ai-system-fragfold-predicts-protein-fragments-0220

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 15 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.